AdaptHealth Corp.
AHCONasdaq
$10.96
↑ +0.6%Jul 17 close · end-of-day
Price
1Y↑ +20.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.5B
Enterprise Value
$3.3B
P/E
—
P/S
0.5
P/B
1.0
EV/EBITDA
7.1
PEG
—
FCF Yield
12.9%
Dividend Yield
—
Revenue (TTM)
$3.3B
Net Income (TTM)
-$79.6M
Free Cash Flow (TTM)
$192.0M
Gross Margin
—
Operating Margin
2.2%
Net Margin
-2.4%
ROE
-5.3%
ROIC
1.7%
Debt / Equity
1.2
Net Cash
-$1.8B
Return 1Y
+19.1%
Company profile
AdaptHealth Corp. provides sleep therapy equipment, supplies, and related services in the United States. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is based in Plymouth Meeting, Pennsylvania.
- CEO
- Stephen P. Griggs
- Sector
- Services
- Industry
- Healthcare
- Employees
- 10,900
- Headquarters
- Pennsylvania
- Website
- adapthealth.com
Management & directors
- Schuster Iii Russell E.Chief Commercial Officer
- Mcfadden Daniel EdwardChief Business Systems Officer
- Prast Albert A.Chief Technology Officer
- Rew Richard W. IiCLO and General Counsel
- Archbold Christine E.Chief Accounting Officer
- Barnhart Toby ScottChief Operating Officer
- Clemens Jason AChief Financial Officer
- Foster SuzanneChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
AHCO Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$819.8M↑ +5.4%
Diluted EPS-$0.12↑ +140.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $2.5B | $3.0B | $3.2B | $3.3B | $3.2B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $71.3M | $225.6M | $190.4M | -$598.4M | $263.7M | $90.9M |
| Net income | -$161.6M | $156.2M | $69.3M | -$678.9M | $90.4M | -$70.8M |
| Diluted EPS | -$3.08 | $0.67 | $0.33 | -$5.31 | $0.61 | -$0.52 |
| Operating cash flow | $195.6M | $275.7M | $373.9M | $480.7M | $541.8M | $601.8M |
| Free cash flow | $155.9M | $72.4M | -$17.6M | $143.2M | $235.8M | $219.4M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 6.8% | 9.2% | 6.4% | -18.7% | 8.1% | 2.8% |
| Net margin | -15.3% | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $806.0M | $805.9M | $856.6M | $777.9M | $800.4M | $820.3M | $846.3M | $819.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $52.0M | $63.5M | $97.7M | $23.2M | $79.3M | $61.7M | -$73.3M | $5.5M |
| Net income | $19.4M | $22.9M | $50.3M | -$7.2M | $14.7M | $24.5M | -$102.8M | -$16.0M |
| Diluted EPS | $0.13 | $0.15 | $0.35 | -$0.05 | $0.10 | $0.16 | -$0.73 | -$0.12 |
| Operating cash flow | $198.0M | $144.4M | $150.4M | $95.5M | $162.0M | $161.1M | $183.2M | $93.7M |
| Free cash flow | $116.7M | $84.8M | $73.1M | -$58,000.00 | $73.3M | $66.8M | $79.3M | -$27.5M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 6.5% | 7.9% | 11.4% | 3.0% | 9.9% | 7.5% | -8.7% | 0.7% |
| Net margin | 2.4% | 2.8% | 5.9% | -0.9% | 1.8% | 3.0% | -12.1% | -2.0% |
Company news
Jul 20, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Schuster III Russell E.· Chief Commercial Officer | Sale | 11,275 | $10.44 | $117,711.00 | filing |
| 2026-06-24 | SAMET KENNETH A | Award | 6,070 | $9.89 | $60,032.30 | filing |
| 2026-06-24 | Connors Terence J | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | BELINFANTI GREGORY | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | Coppens Bradley J | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | Lundberg Theodore B. | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | WOLF DALE B | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | SAMET KENNETH A | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | Williams David Solomon III | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-24 | Weaver Susan T | Award | 18,999 | $0.00 | $0.00 | filing |
| 2026-06-01 | Schuster III Russell E.· Chief Commercial Officer | Sale | 11,275 | $10.06 | $113,426.50 | filing |
| 2026-05-27 | McFadden Daniel Edward· Chief Operating Officer | Award | 20,134 | $0.00 | $0.00 | filing |
| 2026-03-20 | CASHIN RICHARD M JR | Buy | 447,100 | $9.91 | $4.4M | filing |
| 2026-03-20 | OEP VII GP, L.L.C. | Buy | 447,100 | $9.91 | $4.4M | filing |
| 2026-03-19 | CASHIN RICHARD M JR | Buy | 727 | $9.94 | $7,227.62 | filing |
| 2026-03-19 | OEP VII GP, L.L.C. | Buy | 727 | $9.94 | $7,227.62 | filing |
| 2026-03-13 | Prast Albert A.· Chief Technology Officer | Tax withholding | 58,203 | $10.33 | $601,236.99 | filing |
| 2026-03-13 | Prast Albert A.· Chief Technology Officer | Tax withholding | 58,203 | $10.33 | $601,236.99 | filing |
| 2026-03-13 | Prast Albert A.· Chief Technology Officer | Option exercise | 89,451 | $4.38 | $391,795.38 | filing |
| 2026-03-12 | CASHIN RICHARD M JR | Buy | 689,336 | $9.73 | $6.7M | filing |
| 2026-03-12 | OEP VII GP, L.L.C. | Buy | 689,336 | $9.73 | $6.7M | filing |
| 2026-03-11 | OEP VII GP, L.L.C. | Buy | 536,827 | $9.73 | $5.2M | filing |
| 2026-03-11 | CASHIN RICHARD M JR | Buy | 536,827 | $9.73 | $5.2M | filing |
| 2026-03-10 | OEP VII GP, L.L.C. | Buy | 820,528 | $9.73 | $8.0M | filing |
| 2026-03-10 | CASHIN RICHARD M JR | Buy | 820,528 | $9.73 | $8.0M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.